Loading…

Protocol - Perception of Tobacco Product Risk - Cigarettes

Add to My Toolkit
Description

This protocol includes questions from Wave 3 of the Adult Population Assessment of Tobacco and Health Study survey instrument. These specific questions are used to measure a respondent’s perception about the perceived risk of smoking cigarettes. The three response categories range from less harmful to more harmful.

Specific Instructions

The Smoking Cessation, Harm Reduction, and Biomarkers Working Group recommends categorizing respondents based on the following reported use characteristics: (1) ever user versus never user; (2) current established user, defined as everyday user or some-day user; and (3) former established user according to the Use of Tobacco Products protocol. Polyuse with other tobacco products should be considered as well.

Current and former users might also be categorized based on type of cigarette smoked: menthol flavor or nonmenthol flavor. 

The Smoking Cessation, Harm Reduction, and Biomarkers Working Group considers questions 2 and 3 to get at brand descriptors that might modify cigarette risk perceptions.

Protocol

1. Do you think the brand of cigarettes you [usually smoke | usually smoked | last smoked] might be less harmful, no different, or more harmful, compared to other cigarette brands?

1[ ]Less harmful

2[ ]No different

3[ ]More harmful

-8[ ]DONT KNOW

-7[ ]REFUSED

2. Do you think a tobacco product described as additive-free is less harmful, about the same, or more harmful than a regular tobacco product?

1[ ]Less harmful

2[ ]About the same

3[ ]More harmful

-8[ ]DONT KNOW

-7[ ]REFUSED

ASK: All adult respondents.

3. Do you think a tobacco product described as organic is less harmful, about the same, or more harmful than a regular tobacco product?

1[ ]Less harmful

2[ ]About the same

3[ ]More harmful

-8[ ]DONT KNOW

-7[ ]REFUSED

ASK: All adult respondents.

Availability

Available

Personnel and Training Required

None

Equipment Needs

The PhenX Working Group acknowledges that these questions can be administered in a computerized or noncomputerized format (i.e., paper-and-pencil instrument). Computer software is necessary to develop computer-assisted instruments. The interviewer will require a laptop computer/handheld computer to administer a computer-assisted questionnaire.

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Interviewer-administered questionnaire

Life Stage

Adolescent, Adult

Participants

Adult (aged 18 or older)

Adolescent (aged 12-17)

Selection Rationale

The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, in-person longitudinal cohort study of nonusers and users of tobacco products and those at risk for tobacco use across the United States. Respondents aged 12 years or older are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the Food and Drug Administration’s regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.

Language

English, Spanish

Standards
StandardNameIDSource
caDSR Common Data Elements (CDE) Smoking PATH Cigarette Risk Perception Questionnaire 1 Brand Harmfulness Category   7582517 CDE Browser
caDSR Common Data Elements (CDE) Smoking PATH Cigarette Risk Perception Questionnaire 2 Additive   7582519 CDE Browser
caDSR Common Data Elements (CDE) Smoking PATH Cigarette Risk Perception Questionnaire 3 Organic Harmfulness Category 7582524 CDE Browser
Human Phenotype Ontology Addictive behavior HP:0030858 HPO
Derived Variables

None

Process and Review

Not Applicable

Protocol Name from Source

Population Assessment of Tobacco and Health (PATH) Study, PATH Wave 3 Adult Annotated Instrument, 2018

Source

U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse; and U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products, Population Assessment of Tobacco and Health (PATH) Study, 2018, Wave 3 Adult Annotated Instrument, items AC9019, AX0723, AX0724. Distributed October 21, 2020, by Inter-university Consortium for Political and Social Research, Ann Arbor, MI.

General References

Elton-Marshall, T., Driezen, P., Fong, G. T., Cummings, K. M., Persoskie, A., Wackowski, O., Choi, K., Kaufman, A., Strong, D., Gravely, S., Taylor, K., Kwan, J., Bansal-Travers, M., Travers, M., & Hyland, A. (2020). Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Addictive Behaviors, 106, 106337.

Fong, G. T., Elton-Marshall, T., Driezen, P., Kaufman, A. R., Cummings, K. M., Choi, K., Kwan, J., Koblitz, A., Hyland, A., Bansal-Travers, M., Carusi, C., & Thompson, M. E. (2019). U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the PATH Study. Addictive Behaviors, 91, 180-187.

Leas, E. C., Ayers, J. W., Strong, D. R., & Pierce, J. P. (2017). Which cigarettes do Americans think are safer? A population-based analysis with wave 1 of the PATH Study. Tobacco Control, 26(e1), e59-e60.

Pearson, J. L., Johnson, A., Villanti, A., Glasser, A. M., Collins, L., Cohn, A., Rose, S. W., Niaura, R., & Stanton, C. A. (2017). Misperceptions of harm among Natural American Spirit smokers: Results from wave 1 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2014). Tobacco Control, 26(e1), e61-e67.

Protocol ID

330501

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
Smoking Cessation, Harm Reduction and Biomarkers
Measure Name

Perception of Tobacco Product Risk

Release Date

February 23, 2021

Definition

Instrument used to assess respondents’ perception of how much they think people risk harming themselves by using tobacco products and the relative health risk between low-risk products and combustible cigarettes.

Purpose

The purpose of this measure is to collect information from respondents on their thoughts about the physical and health risk associated with using tobacco products. Perceptions of risk of tobacco products are important in predicting first use and continued use.

Keywords

Perceived harm, perceived risk, product risk, Population Assessment of Tobacco and Health, PATH, National Institutes of Health, NIH, U.S. Food and Drug Administration, FDA, Smoking Cessation, Harm Reduction, and Biomarkers, cigarettes, tobacco, e-cigarettes, cigars, pipe tobacco, smokeless tobacco